At today's price, CVS's stock is pricing in about 6.15% annual free-cash-flow growth for the next ten years — a modest ask by market standards. But CVS's actual FCF shrank at -16.1% a year over the past five years, meaning even this modest target still requires a real reversal of a multi-year downtrend.
At its current price, CVS implies ~6.15% annual FCF growth for the next 10 years, discounted at 9%.
CVS's actual 5-year FCF growth was -16.1% a year — it shrank, it didn't grow.
Required growth vs. historical growth
Required growth from the reverse DCF below. Historical CAGRs from 10-K FY2021-FY2025. FCF actually declined over the period, so its bar is shown as a stub rather than a proportional fill.
Sensitivity: what if the discount rate moves?
| WACC | Required growth |
|---|---|
| 8% | 3.89% |
| 9% (base case) | 6.15% |
| 10% | 8.22% |
| 12% | 11.99% |
Even at the lowest discount rate tested (8%), the required growth rate (3.89%) still exceeds the actual 5-year FCF trend (-16.1%) by a wide margin — the conclusion doesn't change much across reasonable discount-rate assumptions.
What would move this number
- Using trailing-twelve-month FCF ($11,758M) instead of the 3-year average ($8,176M) drops the required growth rate sharply, from 6.15% to just 1.33% — reflecting how quickly CVS's cash flow has actually been recovering lately.
- Raising the discount rate to a conservative 12% pushes the required growth rate up to 11.99% — higher than typical for a large, stable company like CVS, so the 9% base case is probably more realistic.
- Lowering the terminal growth rate (fixed at 2.5% here) below that level would actually raise the required near-term growth rate further — this scenario wasn't modeled in this analysis.
Show your work
Inputs, sources, model assumptions, and the calculation
- Share price$93.02 — Yahoo Finance, Aug 21, 2026 close
- Diluted shares outstanding1,287M — 10-Q Q2 FY2026, p.5, 3-month weighted-average diluted shares (period ended Jun 30, 2026)
- Market cap~$119.7B — price × diluted shares (calculated)
- Net debt$50,081M — 10-Q Q2 FY2026 (Jun 30, 2026): $61,410M total debt minus $11,329M cash
- Base FCF (3-year average, normalized)$8,176M — FY2023 ($10,395M) + FY2024 ($6,326M) + FY2025 ($7,807M), averaged
- FCF (TTM, for sensitivity)$11,758M — trailing four quarters through Q2 FY2026
- Discount rate (WACC)9% base case (8-12% tested)
- Terminal growth rate2.5% — long-run GDP-level assumption
Normalization note: TTM FCF ($11,758M) is +43.8% above the three-year average ($8,176M) — beyond the ±40% threshold, so the 3-year average was used as the base case, with the TTM figure shown separately as a sensitivity scenario.
Model: free cash flow is assumed to grow at a constant annual rate g for 10 years, then at a 2.5% terminal rate thereafter, solved by bisection for the value of g that equates present value to today's target enterprise value (market cap $119.7B + net debt $50.08B = $169.78B).
Historical CAGR check: 5-yr FCF CAGR = ($7,807M ÷ $15,745M)^(1/4) − 1 = -16.1%. 5-yr revenue CAGR = ($402,067M ÷ $292,111M)^(1/4) − 1 = +8.3%.
The fine print
- This isn't a fair-value price target — it only shows what the current price already assumes.
- Change the discount rate or the FCF base period, and the answer moves substantially — see the sensitivity table and "what would move it" section above.
- A reverse DCF shows what the market currently expects — it does not say what the stock is "worth."
- Whether 6.15% growth is realistic depends on whether the recent MBR improvement and cash-flow recovery are structural, as covered in the story piece above — not on this math alone.
- Any investment decision, and its outcome, is your own responsibility.
Frequently asked questions
What growth rate does CVS's stock price assume?
At today's price, CVS's stock is pricing in about 6.15% annual free-cash-flow growth for the next ten years, at a 9% discount rate using a 3-year-average FCF base.
How does that compare to CVS's actual growth?
CVS's actual FCF shrank at -16.1% a year over the past five years (2021-2025) — the current price still requires reversing that multi-year decline, even though the required growth rate itself (6.15%) is relatively modest.
What share price was used for this analysis?
This analysis used $93.02, as of the Aug 21, 2026 close.